107
Views
3
CrossRef citations to date
0
Altmetric
Research Article

rhEGF microsphere formulation and in vitro skin evaluation

, , &
Pages 14-24 | Received 09 Jan 2009, Accepted 14 Jan 2009, Published online: 18 Jan 2010

References

  • Akkarainen M. Aliphatic polyesters: Abiotic and biotic degradation and degradation products. Adv Polym Sci 2002; 157: 113–138
  • Al haushey L, Bolzinger MA, Bordes C, Gauvrit JY, Briancon S. Improvement of a bovine serum albumin microencapsulation process by screening design. Int J Pharm 2007; 344: 16–25
  • Bilati U, Allemann E, Doelker E. Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles. Eur J Pharm Biopharm 2005; 59: 375–388
  • Bos JD, Meinardi MMHM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol 2000; 9: 165–169
  • Buckley A, Davidson JM, Kamerath TBW, Woodward SC. Sustained release of epidermal growth factor accelerates wound repair. Proc Natl Acad Sci USA 1985; 82: 7340–7344
  • Celebi N, Turkyilmaz A, Gonul B, Ozogul C. Effects of epidermal growth factor microemulsion formulation on the healing of stress-induced gastric ulcers in rats. J Contr Rel 2002; 83: 197–210
  • Cohen S, Carpenter J. Human epidermal growth factor: Isolation and chemical and biological properties. Proc Natl Acad Sci USA 1975; 72: 1317
  • Falanga V, Eaglstein WH, Bucalo B, Katz MH, Harris B, Carson P. Topical use of human recombinant epidermal growth factor (hEGF) in venous ulcer. J Dermatol Surg Oncol 1992; 18: 604–606
  • Giteau A, Venier-Julienne MC, Aubert-Pouëssel A, Benoit JP. How to achieve sustained and complete protein release from PLGA-based microparticles?. Int J Pharm 2008; 350: 14–26
  • Grayson LS, Hansbrough JF, Zapata-Sirvent RL, Dore CA, Morgan JL, Nicolson MA. Quantitation of cytokine levels in skin graft donor site wound fluid. Burns 1993; 19: 401–405
  • Greenhalgh DG. The role of growth factors in wound healing. J Trauma 1996; 41: 159–167
  • Grzybowski J, Oldak E, Antos-Bielska M, Janiak MK, Pojda Z. New cytokine dressings. Kinetics of the in vitro rhG-CSF, rhGM-CSF, and rhEGF release from the dressings. Int J Pharm 1999; 184: 173–178
  • Guglietta A, Sullivan PB. Clinical applications of epidermal growth factor. Eur J Gastroenterol Hepatol 1995; 7: 945–950
  • Han K, Choi MS, Chung YB. Site-specific degradation and transport of recombinant human epidermal growth factor (rhEGF) in the rat gastrointestinal mucosa. Int J Pharm 1998; 168: 189–197
  • Han K, Lee KD, Gao SG, Park JS. Preparation and evaluation of poly(L-lactide acid) microspheres contatining rhEGF chronic ulcer healing. J Contr Rel 2001; 75: 259–269
  • de Jalon EG, Blanco-Prıeto MJ, Ygartua P, Santoyo S. Topical application of acyclovir-loaded microparticles: Quantification of the drug in porcine skin layers. J Contr Rel 2001; 75: 191–197
  • Kim TH, Lee H, Park TG. Pegylated recombinant human epidermal growth factor release from biodegradable PLGA microspheres. Biomaterials 2002; 23: 2311–2317
  • Kwon YM, Baudys M, Knutson K, Kim SW. In situ study of insulin aggregation induced by water–organic solvent interface. Pharm Res 2001; 18: 1754–1759
  • Lemoine D, Francois C, Kedzierewicz F, Preat V, Hoffman M, Maincent P. Stability study of nanoparticles of poly(epsilon-caprolactone), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide). Biomaterials 1996; 17: 2191–2197
  • Li H, Song JH, Park JS, Han K. Polyethylene glycol-coated liposomes for oral delivery of recombinant human epidermal growth factor. Int J Pharm 2003; 258: 11–19
  • Mustoe TA, Pierce GF, Morishima C, Deuel TF. Growth factor-induced acceleration of tissue repair through direct and inductive activities in a rabbit dermal ulcer model. J Clin Invest 1991; 87: 694–703
  • Pastor JC, Calonge M. Epidermal growth factor and corneal wound healing. A multicenter study. Cornea 1992; 11: 311–314
  • Rolland A, Wagner N, Chatelus A, Shroot B, Schaefer H. Site-specific drug delivery to pilosebaceous structure using polymeric microspheres. Pharm Res 1993; 10: 1738–1744
  • Scardovi C, De-Felice GP, Gazzaniga A. Epidermal growth factor in the topical treatment of traumatic corneal ulcers. Ophtalmologica 1993; 206: 119–124
  • Senderoff RI, Wootton SC, Boctor AM, Chen TM, Giordani AB, Julian TN, et al. Aqueous stability of human epidermal growth factor 1-48. Pharm Res 1994; 11: 1712–1720
  • Sharif S, O’Hagan DT. A comparison of alternative methods for the determination of the levels of proteins entrapped in poly(lactide-co-glycolide) microparticles. Int J Pharm 1995; 115: 259–263
  • Singer AJ, Clark RAF. Cutaneous wound healing. N Eng J Med 1999; 341: 738–744
  • Sinha VR, Trehan A. Biodegradable microspheres for protein delivery. J Contr Rel 2003; 90: 261–280
  • Steed DL. Modyfing the wound healing response with exogenous growth factors. Clin Plast Surg 1998; 25: 397–405
  • Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003; 83: 835–870
  • Wolf M, Wirth M, Pittner F, Gabor F. Stabilisation and determination of the biological activity of L-asparaginase in poly(D,L-lactide-co-glycolide) nanospheres. Int J Pharm 2003; 256: 141–152
  • Yang CH, Huang YB, Wu PC, Tsai YH. The evaluation of stability of recombinant human epidermal growth factor in burn-injured pigs. Process Biochem 2005; 40: 1661–1665

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.